Evidence map›Paper›PMID 30276558›Full record

ArticleInflammopharmacology2019

Luteolin suppresses inflammation through inhibiting cAMP-phosphodiesterases activity and expression of adhesion molecules in microvascular endothelial cells.

Xueli Kong, Guitao Huo, Shurong Liu, Fengnan Li, Wu Chen, Daixun Jiang

Abstract read
PubMed Publisher
In one paragraph

Article in Inflammopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xueli KongBeijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, 7 Beinong Road, Huilongguan Town, Changping District, Beijing, 102206, China.
Guitao HuoNational Center for Safety Evaluation of Drugs, National Institutes for Food and Drug Control, Beijing, 100050, China.
Shurong LiuBeijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, 7 Beinong Road, Huilongguan Town, Changping District, Beijing, 102206, China.
Fengnan LiBeijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, 7 Beinong Road, Huilongguan Town, Changping District, Beijing, 102206, China.
Wu ChenBeijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, 7 Beinong Road, Huilongguan Town, Changping District, Beijing, 102206, China.
Daixun JiangBeijing Key Laboratory of Traditional Chinese Veterinary Medicine, Beijing University of Agriculture, 7 Beinong Road, Huilongguan Town, Changping District, Beijing, 102206, China. dx_tcvm@126.com.ORCID http://orcid.org/0000-0002-8539-6870
Beijing University of Agriculture · CNNational Institutes for Food and Drug Control · CN

Funding

National Natural Science Foundation of China 31101851National Natural Science Foundation of China 31540059
6 · The paper itself

Abstract

Luteolin, an anti-inflammatory ingredient found in the Chinese herb Folium perillae, can inhibit not only the cyclic adenosine monophosphate (cAMP)-phosphodiesterases (PDEs) activity of neutrophils, but also the expression of lymphocyte function-associated antigen-1 in neutrophils, both of which result in a decrease in the adhesion between neutrophils and microvascular endothelial cells. However, the effect of luteolin on the cAMP-PDEs activity and expression of adhesion molecules in endothelial cells are not clear. In the present study, primary rat pulmonary microvascular endothelial cells and a lipopolysaccharide-induced rat acute pneumonia model were used to explore the role of luteolin on cAMP-PDEs activity, expression of adhesion molecules, and leukocyte infiltration. We demonstrate that rat pulmonary microvascular endothelial cells expressed high levels of cAMP-PDEs, specifically PDE4, and further luteolin exhibited dose-dependent inhibition on the activity of cAMP-PDEs or PDE4 in endothelial cells. Luteolin also had a significant inhibitory effect on the expression of vascular cell adhesion molecule (VCAM)-1, but not intracellular cell adhesion molecule (ICAM)-1 in microvascular endothelial cells. Further, we show that luteolin decreased the levels of soluble ICAM-1 (sICAM-1), but not soluble E-selectin in the serum of rats subjected to acute pneumonia. We also show that luteolin treatment decreased the wet/dry weight ratio of lung tissue and reduced the total number of serum leukocytes in a dose-dependent manner in a rat acute pneumonia model. In conclusion, these results demonstrate that luteolin suppresses inflammation, at least in part, through inhibiting both cAMP-PDEs or PDE4 activity and the expression of VCAM-1 (in vitro) and sICAM-1 (in vivo) in endothelial cells.

Indexed as

AnimalsCell Adhesion MoleculesCells, CulturedCyclic AMPDisease Models, AnimalEndothelial CellsEndothelium, VascularInflammationLeukocytesLungLuteolinNeutrophilsPhosphodiesterase InhibitorsPhosphoric Diester HydrolasesPneumoniaRatsCell Adhesion MoleculesCyclic AMPLuteolinPhosphodiesterase InhibitorsPhosphoric Diester HydrolasesVascular Cell Adhesion Molecule-1Adhesion moleculesLuteolinMicrovascular endothelial cellsPhosphodiesteraseRat

Identifiers

PMID30276558
OpenAlexW2895365941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.